The drug business is undergoing a radical change from pill packs that disrupt pharmacies to more retail services in more places to apps that being prescribed as adjuvant therapies. Join us for an evening of experts, innovators, and networking with others who also care deeply about driving innovation in the drug industry.
Dan Conley - Managing Director, NJ Angels, Active Investor in Drug Discovery Automation - Dan Conley does three things: Invests in private early stage life sciences companies, supports CEOs whom he backs as OnCallCFO and coordinates Entrepreneurs University programs (EntreUniv.org) for CEOs learning Best Practices to start capitalize and grow their technology-based enterprise.
His Conley Family Office leads other Angels to co-invest, under reciprocal Due Diligence treaties.
Grace Cordovano, PhD - Enlightening Results - CEO / Private Cancer Patient Advocate - Upon recognizing significant unmet needs and challenges in patients’ journeys throughout their cancer diagnosis, Dr. Grace Cordovano founded Enlightening Results, LLC in 2010. As the culmination of her life’s experiential learning and education, Dr. Cordovano is dedicated to fostering private, personalized patient advocacy services, specializing in the cancer arena. She strategically and empathetically guides her clients through survivorship or end-of-life care, ensuring they are armed with the most pertinent, medically credible, easy to understand information so as to make empowered decisions about their care. Grace is a firm believer in the continuous advancement and improvement of cancer patient experiences through the infusion of empathic design and thinking into current healthcare paradigms. A frequent questioner of the status quo, she leaves no stone or process unturned in her quest to improve overall patient experiences across the continuum of patient care. She's motivated to have patient and caregiver stories included throughout the entire healthcare ecosystem and considers herself a patient voice activator. Grace is a proud member of the Alliance of Professional Health Advocates and the Society for Participatory Medicine. Tweet to her at @GraceCorovano.
Jodie Gillon - Achillion Pharmaceuticals, Senior Director, Patient Advocacy and Professional Affairs. Jodie is primarily responsible for Policy, Alliances, Patient Engagement, Medical Information, Medical Communications, Field Medical and management of Meetings and HCP engagements. Previously she served as the Head of the External Interface/Chief Medical Office (CMO) of AstraZeneca. She led the Payment Transparency, Trial Transparency and Global Conference and Events teams. As Head of the CMO, Jodie managed companywide policy, financial contributions, alliances, crisis management and gatekeeping. She represented AZ externally on committees such as PHRMA, EFPIA, NIH, FDA, IOM and the CMO roundtable. She was also the organizational lead for Early Access/Compassionate Use and HCP Engagements. For nine years prior to AZ, Jodie served as the Director, External Medical Communications with Pfizer. In addition to overseeing Communications for the Specialty Care and Emerging Markets Business units, she led an External Collaborations Alliance focused on academic centers, publishing companies, societies and thought leaders. As part of Pfizer’s Transparency team, she played a pivotal role in implementing the PhRMA/EFPIA Principles and integrating vendors and systems after the Wyeth merger.Prior to Pfizer, Jodie was a Global Communications lead at Novartis and managed a Phase IV/IIR review board. She served as the Director of Medical Education for Oridion Medical and as a Health Economist with the Israeli Center for Disease Control and Ministry of Health. She has held additional roles in academia, advocacy and the White House. Jodie holds a Master’s of Public Health with a dual degree in Health Economics and Epidemiology and a BSFS from Georgetown’s School of Foreign Service.
Moderated by Anthony Manson, Co-Organizer H2NYC and Chief Digital Officer /alert Marketing - Pioneer in Digital Advertising and Media with expertise in the healthcare industry leading the development of many award-winning efforts to improve healthcare and educate both physicians and consumers. Extensive work in health care technology and the pharmaceutical industry. Tweet Anthony at @DigitalRants
Early Stage Companies Presenting
ClearRx - A simple and easy way to choose the best health plan based on a consumer’s individual need. Visit ClearRxPlan.com
Clinical Trials Connect - To accelerate the discovery of cures and treatments, disease foundations want to promote clinical trial awareness to their communities. ClinicalTrialsConnect helps this effort by enabling a foundation to offer patients a personalized, trial matching experience on their own website. Visit ClinicalTrialConnect.com.
OneThreeBiotech - OneThree Biotech is developing an artificial intelligence platform to more rapidly identify drug targets, utilizing diverse data types beyond simple molecular structure to more accurately identify targets and side effects with greater flexibility and speed. Twitter: @OneThreeBiotech
6 PM - Meet Tweet & Greet - healthy snacks and networking time
6:15 - Opening Remarks and Keynote
6:30 - Several Innovators in the space present their innovations to a panel of experts and our crowd who ask questions
7:15 - Networking Break
7:45 - Panel Discussion - PharmaTech Innovation Perspectives with a panel of experts
8:15 - Open Bar and Networking Time!
9:00 - After Event off site
We have many events coming up so please be welcome to browse or suggest a topic.
Are you an expert in the area or do you want to present your idea or company at an Event?
Thank you for your support for this group and our mission. If you have an idea, please be welcome to use the "Suggest a meetup" option above. Many of our best ideas are crowd sourced and we appreciate your input.
1212 6th ave. (between 48 and 47 st.